The global race to develop so-called “double G” and “triple G” agonists is heating up to boost the efficacy of…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Nippon Shinyaku to Gear Up R&D, Commercialization of Nucleic Acid Products
September 17, 2014
-
BUSINESS Pharmacy Chains Hurrying to Reach Price Settlements with Wholesalers ahead of Sept.-End Deadline
September 16, 2014
-
BUSINESS Takara Bio Pushes for Melanoma Drug Development with Eye on Fast Approval
September 12, 2014
-
REGULATORY Chuikyo’s Drug Pricing Panel to Continue Discussions on Penalties and Actions against Novartis
September 11, 2014
-
REGULATORY Jichi Medical University President Seen as Prime Candidate for Japan NIH Head
September 10, 2014
-
ACADEMIA Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study
September 9, 2014
-
BUSINESS All Eyes Glued to Japan Realignment after Mylan’s Buyout of Abbott’s Established Product Biz
September 8, 2014
-
BUSINESS MSD’s Januvia Logs 1st Sales Decline in Japan on Re-Pricing
September 5, 2014
-
BUSINESS US Court Backs Jury Verdict in Actos Suit, Orders Takeda to Pay US$6 Billion in Punitive Damages
September 5, 2014
-
REGULATORY Industry on Alert as Reformist Shiozaki Tapped as New Health Minister
September 4, 2014
-
REGULATORY Yasuhisa Shiozaki Tapped as New Health Minister
September 3, 2014
-
REGULATORY MOF Official Unami Urges Full-Scale NHI Price Revision upon Next Sales Tax Hike
September 2, 2014
-
BUSINESS Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs
September 1, 2014
-
BUSINESS Sanofi Greater China Head Baschiera to Shepherd Japan Unit
August 29, 2014
-
BUSINESS Roche Obtains First Refusal Right for All Chugai’s Products with Partial Amendment to Strategic Alliance Deal
August 29, 2014
-
REGULATORY Chuikyo Grants Unprecedented 60% Premium to Ono’s Opdivo
August 28, 2014
-
BUSINESS Otsuka Holdings Takes Aim at 915 Billion Yen Pharma Sales in FY2018 after Abilify Patent Loss
August 27, 2014
-
ORGANIZATION CDISC CEO Advises Drug Makers to Collect Data Based on CDASH
August 27, 2014
-
REGULATORY PAFSC Second Committee to Review Nobelpharma’s Anticancer Drug Streptozocin on Sept. 5
August 26, 2014
-
BUSINESS Latuda Goes on Sale in UK: Sumitomo Dainippon
August 25, 2014
ページ
1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…